ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Melanoma progression involves complex molecular events crucial for developing new treatments.
• The oncogenic SOX2-GLI1 transcriptional complex is implicated in driving cancer cell invasion.

Purpose of the Study:

• To elucidate the mechanism by which the SOX2-GLI1 complex drives melanoma invasion.
• To investigate the role of sialyltransferase ST3GAL1 in melanoma metastasis.
• To identify therapeutic targets for metastatic melanoma.

Main Methods:

• In vitro and in vivo studies were conducted.
• Gene silencing techniques were used to inhibit ST3GAL1 expression.
• Analysis of glycosylated proteins, including receptor tyrosine kinase AXL, was performed.
• AXL dimerization and activation were assessed.

Main Results:

• The SOX2-GLI1 complex induces ST3GAL1, which drives melanoma invasion and metastasis.
• Silencing ST3GAL1 suppressed melanoma invasion and reduced metastasis.
• ST3GAL1 activates the receptor tyrosine kinase AXL, promoting invasion.
• The ST3GAL1-AXL axis was identified as a key driver of melanoma metastasis.

Conclusions:

• The ST3GAL1-AXL axis is a critical mediator of melanoma metastasis.
• Targeting the ST3GAL1-AXL axis presents a promising therapeutic strategy for metastatic melanoma.